This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Abraham, P. A. Articles by Andersen, R. C. Search for Related Content PubMed PubMed Citation Articles by Abraham, P. A. Articles by Andersen, R. C.

Hypertension, Vol 16, 669-676, Copyright © 1990 by American Heart Association

ARTICLES

Renal secretion and hepatic clearance of human multiple renin forms

PA Abraham, SA Katz, JA Opsahl, RP Miller, WR Stanchfield Jr and RC Andersen
Department of Medicine, Hennepin County Medical Center, Minneapolis, Minn.

Human active renin can be separated into at least five forms by isoelectric focusing. The present study assessed the preferential renal secretion and hepatic degradation of renin forms in humans. The renin form profile of secreted renal renin was determined before transplant in an ex vivo kidney donor perfusion system and compared with the peripheral plasma multiple renin form profile of normal subjects. The effect of hepatic degradation on renin forms was assessed in hepatic vein plasma in comparison with infrarenal vena cava plasma in hypertensive patients during renal vein renin studies. The results revealed a significantly greater proportion of the more basic forms in the perfusate of donor kidneys compared with normal plasma. In hypertensive patients the proportion of the more basic renin forms in the hepatic vein was significantly decreased in comparison with the infrarenal vena cava. Thus, the human kidney may preferentially secrete the more basic renin forms. In contrast, the liver preferentially degrades the more basic forms, giving these forms a shorter plasma half- life. The preferential secretion and clearance of the more basic forms of renin may contribute to short-term control of human renin- angiotensin system activity.

This article has been cited by other articles:

				P. L. Storring, C-T. Yuen, V. Skibeli, G. Nissen-Lie, and P. Torjesen Differences between the N-glycans of human serum erythropoietin and recombinant human erythropoietin Blood, February 1, 2003; 101(3): 1204 - 1204. [Full Text] [PDF]

				A.H.J. Danser, J. J Saris, M. P Schuijt, and J. P van Kats Is there a local renin--angiotensin system in the heart? Cardiovasc Res, November 1, 1999; 44(2): 252 - 265. [Abstract] [Full Text] [PDF]

				P. A. Vincent and E. De Vito Rat Renal and Plasma Prorenin Are Activated In Vitro by Different Mechanisms Hypertension, September 1, 1999; 34(3): 520 - 524. [Abstract] [Full Text] [PDF]

				S. A. Katz, J. A. Opsahl, M. M. Lunzer, L. M. Forbis, and A. T. Hirsch Effect of Bilateral Nephrectomy on Active Renin, Angiotensinogen, and Renin Glycoforms in Plasma and Myocardium Hypertension, August 1, 1997; 30(2): 259 - 266. [Abstract] [Full Text]